The full submission pathway, pre-screening, dossier intake, classification, technical committee review, pricing, certificate issuance, with the timeline ranges we observe in practice.
A practical path to a DHA licensed home healthcare and telehealth operation in Dubai, from Sheryan filing to NABIDH, DESC, and TDRA compliance.
ReadHow the UAE's risk-based device classes work, who assigns them under the EDE, and what each class means for your dossier and timeline.
ReadEDE inspections of foreign manufacturing sites are discretionary, not guaranteed: how the documentary review works and how to pass it first time.
ReadCompounding pharmacy licensing stayed with MOHAP under the 2025 law: what that carve-out covers, and where the EDE still governs your supply chain.
ReadHow to assess UAE distributor candidates, structure the agreement, and use an independent MAH so changing partners never puts your registration at risk.
ReadWhat happens after the certificate: pricing, import permits, GDP warehousing, distributor onboarding, and channel listing, mapped as one pathway.
ReadA module by module checklist for UAE CTD submissions, covering bilingual documents, BE data for generics, and the gaps that trigger deficiency letters.
ReadWhat a UAE medical warehouse licence requires, the EDE steps in order, and how to hold stock before your own licence issues.
ReadBioequivalence evidence against the innovator belongs inside the CTD dossier, no local UAE studies are required, and comparator choice decides the file.
ReadThe permit behind every UAE pharmaceutical consignment: who applies, which permit type fits, what the application needs, and why files get rejected.
ReadWho may import APIs into the UAE, what documentation the EDE expects from a source, and how a compliant consignment cycle runs.
ReadWhy every peptide project starts with EDE classification, the registered pathway from site registration to import permit, and the risks of unregistered supply.
ReadWhat a Dubai telehealth licence involves: DHA Sheryan requirements, NABIDH, DESC, and TDRA approvals, fee categories, and an approximately 45 day setup.
ReadA clear map of UAE regulators after the 2025 law: what the EDE took over, what MOHAP kept, and where DHA fits.
ReadThe full EDE registration sequence for foreign manufacturers, from site registration and classification to CTD dossier, certificate, and importation.
ReadRisk classes, IFU language, technical file depth, and where most foreign manufacturers misjudge their device's risk category.
ReadThe transition from MOHAP-only pathways to EDE-centralised review, what changes, what doesn't, and what to file where.
ReadProvider eligibility, controlled medicine prescribing, and the operational changes telehealth operators need to make by Q4.
ReadA practitioner's walkthrough of NABIDH onboarding via certified EMR vendors, vendor selection, data flow, and conformance testing.
ReadPV Master File requirements, QPPV qualifications, and the reporting cadence MOHAP expects from registered MAHs.
ReadWhat the UAE Pharmacopoeia covers, where it diverges from USP/EP/BP, and how to align your CTD module 3 accordingly.
ReadWhat an AR actually does in the UAE, the post-market obligations attached, and the contractual structures we use with foreign OEMs.
ReadTemperature mapping, validated lanes, and the documentation regulators expect when your product enters at 2 to 8°C or below.
ReadReference pricing, external benchmarking, and the negotiation cadence we observe in the MOHAP pricing committee.
Read